BONE MARROW AND CANCER FOUNDATION INC
Mission Statement
The Bone Marrow & Cancer Foundation, founded in 1992, is dedicated to improving the quality of life for cancer and transplant patients and their families by providing vital financial assistance, comprehensive resources, educational information, physician referrals, and emotional support programs. Guided by a medical advisory board of nationally-recognized cancer specialists and working with hospitals across the United States, the Bone Marrow & Cancer Foundation is the only organization of its kind that does not limit assistance to a specific disease, type of transplant or age range. For over 30 years, the Foundation has connected patients and their families with the services they need—from diagnosis through survivorship—to make effective decisions about treatment and its aftermath. All of the Foundation’s programs and services are offered to patients and their families free of charge.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.1% | 84.9% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.9% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.0% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
41.2% | 125.2% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.2 mo | 9.7 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
20.5% | 14.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.8% | 91.3% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-19.7% | 5.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
15.0% | 9.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-29.3% | 1.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.6M | $2.1M | $1.6M | 80.1% | 8 |
| 2022 | $2.0M | $1.8M | $2.1M | 79.1% | 9 |
| 2021 | $2.2M | $1.4M | N/A | — | 4 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.